Viridian Therapeutics (VRDN)
(Delayed Data from NSDQ)
$13.47 USD
-1.37 (-9.23%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $13.48 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -1.10 |
EPS Last Quarter | -1.02 |
Last EPS Surprise | -17.24% |
ABR | 1.27 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.97 |
Next Year | -4.29 |
EPS (TTM) | -4.25 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.08M | 0.09M | 0.21M | 0.55M |
# of Estimates | 4 | 4 | 7 | 3 |
High Estimate | 0.10M | 0.10M | 0.35M | 1.00M |
Low Estimate | 0.07M | 0.07M | 0.01M | 0.30M |
Year ago Sales | 0.07M | 0.07M | 0.31M | 0.21M |
Year over Year Growth Est. | 17.14% | 24.29% | -34.71% | 168.29% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.10 | -1.05 | -3.97 | -4.29 |
# of Estimates | 8 | 8 | 8 | 7 |
Most Recent Consensus | -1.13 | -1.08 | -4.02 | -4.12 |
High Estimate | -0.93 | -0.91 | -3.69 | -3.69 |
Low Estimate | -1.18 | -1.20 | -4.14 | -5.38 |
Year ago EPS | -1.09 | -1.35 | -5.31 | -3.97 |
Year over Year Growth Est. | -0.92% | 22.22% | 25.24% | -8.16% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 2 | 0 | 1 |
Up Last 60 Days | 1 | 2 | 0 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 7 | 6 | 8 | 6 |
Down Last 60 Days | 7 | 6 | 8 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.10 | -1.05 | -3.97 | -4.29 |
7 Days Ago | -1.10 | -1.05 | -3.97 | -4.29 |
30 Days Ago | -0.95 | -0.95 | -3.61 | -3.86 |
60 Days Ago | -0.95 | -0.95 | -3.61 | -3.94 |
90 Days Ago | -0.95 | -0.95 | -3.61 | -3.84 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.10 | -1.05 | -3.97 | -4.29 |
Zacks Consensus Estimate | -1.10 | -1.05 | -3.97 | -4.29 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.02 | -0.79 | -1.35 | -1.09 | NA |
Estimate | -0.87 | -1.07 | -1.08 | -1.22 | NA |
Difference | -0.15 | 0.28 | -0.27 | 0.13 | 0.00 |
Surprise | -17.24% | 26.17% | -25.00% | 10.66% | -1.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more